Latest Posts
CENTERLINE BIOMEDICAL COMPLETES FIFTH STUDY ON IOPS SURGICAL NAVIGATION SYSTEM AT CLEVELAND CLINI
Endovascular navigation startup Centerline Biomedical has successfully completed a fifth preclinical study at Cleveland Clinic facilities to see how its surgical navigation system, the Intra-Operative Positioning System (IOPS), will perform in the marketplace. The study demonstrated its ability to track IOPS instruments precisely and efficiently with enhanced three-dimensional (3D) visualization and
COOK GROUP EXPANDS BY BUYING ADJACENT VACANT GE SITE
Cook Group, through its subsidiary Cook Properties, has agreed to purchase the former GE site near Cook’s world headquarters in Bloomington, Ind. Cook Group is expanding its medical device business into the vacant GE property on Curry Pike. This purchase allows Cook the flexibility to address some immediate space
BECTON, DICKINSON COMPLETES ACQUISITION OF C.R. BARD
Becton, Dickinson (BD) has completed the acquisition of C.R. Bard, creating a new healthcare company with approximately $16 billion in annualized revenue. Vincent A Forlenza, chairman and CEO, said the combined company builds on BD’s position in medication management and infection prevention with an expanded offering of solutions across the care
PRISM TRIAL EVALUATES SAFETY, EFFICACY OF INDIGO ASPIRATION SYSTE
Results of the multicenter PRISM trial were published by Richard R. Saxon, MD, et al in the Journal of Vascular and Interventional Radiology (JVIR; 2018;29:92–100). PRISM evaluated the safety and initial efficacy of a power aspiration–based extraction technique for treatment of peripheral arterial thromboembolism using the Indigo aspiration system from Penumbra Inc.. The JVIR investigators
FDA APPROVES XABLECATH BLUNT TIP SUPPORT CATHETER
XableCath’s blunt tip support catheter has received clearance from the U.S. Food and Drug Administration (FDA). In two clinical investigator-led studies, the device was demonstrated to be a safe, effective, and easy-to-use device, enabling therapeutic options for patients with PAD,” said Johannes Dahm, MD and director of Interventional Cardiology